Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
India surprised the world when it announced in July that it is home to 2.5 million infected individuals—fewer than half of the previous estimate. Ashok Alexander, director of the Bill & Melinda Gates Foundation's Indian initiative on AIDS explains why the dramatically lower numbers are no reason to celebrate.
On 27 April, the US Food and Drug Administration rejected Merck's application for Arcoxia, a Cox-2-targeting painkiller widely seen as the successor to the ill-fated Vioxx. The fate of Vioxx, Arcoxia's rejection—and the dearth of other effective painkillers in the market—begs the question...
Without physician scientists, many clinical trials and new drug studies would grind to a halt. Tinker Ready discovers why few young doctors are choosing a career in research.